Human immunodeficiency virus antibody screening in blood donors from India, Nigeria and Thailand.
Screening for human immunodeficiency virus (HIV) (LAV/HTLV-III) antibodies in 3 blood donor populations from India (n = 1,000), Nigeria (n = 500) and Thailand (n = 650; sampling in 1982) with a sensitive enzyme immunoassay (EIA; Abbott) yielded seropositivity rates of 0.5, 2.2 and 1.7%, respectively. Two EIAs with control antigens prepared from uninfected cell cultures ('ELAVIA', VIRGO'), a recombinant Escherichia coli DNA EIA ('ENV/CORE'), Western blot, an immunofluorescence assay and a radio-immunoprecipitation assay confirmed none of the EIA-reactive specimens as truly positive. The lack of specificity of the screening test was also attributable to monochromatic evaluation of the test trays at 492 nm only, and to reactivities against determinants of H9 cells used to grow HIV (HLA antibodies).
Kühnl
P
P
Seidl
S
S
Ray
V
V
Kulkarni
A G
AG
Mba
E C
EC
Chandanayingyong
D
D
D000914:Antibodies, Viral / Q000032:analysis*; D001782:Blood Donors; D006678:HIV / Q000276:immunology*; D015483:HIV Antibodies; D006801:Humans; D007124:Immunoenzyme Techniques; D007194:India; D008403:Mass Screening; D009549:Nigeria; D013785:Thailand
D000914:Antibodies, Viral; D015483:HIV Antibodies